Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 391

1.

Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.

Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, Weiss NS.

Gastroenterology. 2013 Aug;145(2):312-9.e1. doi: 10.1053/j.gastro.2013.05.004.

2.

Barrett's surveillance identifies patients with early esophageal adenocarcinoma.

Wong T, Tian J, Nagar AB.

Am J Med. 2010 May;123(5):462-7. doi: 10.1016/j.amjmed.2009.10.013.

PMID:
20399324
3.

Surveillance in Barrett's esophagus: an audit of practice.

Ajumobi A, Bahjri K, Jackson C, Griffin R.

Dig Dis Sci. 2010 Jun;55(6):1615-21. doi: 10.1007/s10620-009-0917-y.

PMID:
19669878
4.

Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.

Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A, Young PE, Cash BD, Bansal A, Vargo JJ, Falk GW, Lieberman DA, Sampliner RE, Sharma P.

Gastroenterology. 2013 Sep;145(3):548-53.e1. doi: 10.1053/j.gastro.2013.05.040.

PMID:
23714382
5.

Is Barrett's metaplasia the source of adenocarcinomas of the cardia?

Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR.

Arch Surg. 1994 Jun;129(6):609-14.

PMID:
8204035
6.

[Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].

Incarbone R, Bonavina L, Bassi F, Peracchia A.

Chir Ital. 2002 Sep-Oct;54(5):591-6. Italian.

PMID:
12469454
7.

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma.

Grant KS, DeMeester SR, Kreger V, Oh D, Hagen JA, Chandrasoma P, DeMeester TR.

J Thorac Cardiovasc Surg. 2013 Jul;146(1):31-7. doi: 10.1016/j.jtcvs.2012.12.058.

8.

Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients.

Ferguson MK, Durkin A.

J Gastrointest Surg. 2002 Jan-Feb;6(1):29-35; discussion 36.

PMID:
11986015
9.

The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.

Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D.

Am J Gastroenterol. 1998 Apr;93(4):536-41.

PMID:
9576444
10.

Mortality in Barrett's esophagus: three decades of experience at a single center.

Caygill CP, Royston C, Charlett A, Wall CM, Gatenby PA, Ramus JR, Watson A, Winslet M, Bardhan KD.

Endoscopy. 2012 Oct;44(10):892-8. doi: 10.1055/s-0032-1309842.

PMID:
22752886
11.

Barrett's esophagus: a retrospective analysis of 13 years surveillance.

Switzer-Taylor V, Schlup M, L├╝bcke R, Livingstone V, Schultz M.

J Gastroenterol Hepatol. 2008 Sep;23(9):1362-7. doi: 10.1111/j.1440-1746.2008.05311.x.

PMID:
18205769
12.

Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus.

Fitzgerald RC, Saeed IT, Khoo D, Farthing MJ, Burnham WR.

Dig Dis Sci. 2001 Sep;46(9):1892-8.

PMID:
11575441
13.

Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.

Kestens C, Leenders M, Offerhaus GJ, van Baal JW, Siersema PD.

Endoscopy. 2015 May;47(5):409-14. doi: 10.1055/s-0034-1391091.

PMID:
25521571
14.

[Endoscopic diagnosis of Barrett's adenocarcinoma].

Yoshio H, Takashi Y, Mitsuyo H, Nobuhiko Y, Tatsurou T, Kazuhiko S, Yoko H, Shigemasa I, Hisanaga M, Osamu H, Katsuyoshi S, Seishi U, Matsushita H, Masahiko T.

Nihon Geka Gakkai Zasshi. 1999 Mar;100(3):244-8. Review. Japanese.

PMID:
10379534
15.

Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.

Coleman HG, Bhat SK, Murray LJ, McManus DT, O'Neill OM, Gavin AT, Johnston BT.

Am J Gastroenterol. 2014 Apr;109(4):527-34. doi: 10.1038/ajg.2014.10.

PMID:
24589668
16.

A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance.

Gudlaugsdottir S, van Blankenstein M, Dees J, Wilson JH.

Eur J Gastroenterol Hepatol. 2001 Jun;13(6):639-45.

PMID:
11434588
18.

Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.

Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.

Am J Gastroenterol. 2009 Nov;104(11):2673-80. doi: 10.1038/ajg.2009.437.

PMID:
19638963
19.

Audit of a Barrett's epithelium surveillance database.

Basu KK, Pick B, de Caestecker JS.

Eur J Gastroenterol Hepatol. 2004 Feb;16(2):171-5.

PMID:
15075990
20.

Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.

Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA.

Ann Thorac Surg. 2005 May;79(5):1716-23.

PMID:
15854962
Items per page

Supplemental Content

Support Center